Diego F Ferro Md Inc | |
420 W Acacia St Suite 1 Stockton CA 95203-2441 | |
(209) 948-1583 | |
(209) 948-3564 |
Full Name | Diego F Ferro Md Inc |
---|---|
Speciality | Internal Medicine |
Location | 420 W Acacia St, Stockton, California |
Authorized Official Name and Position | Diego F Ferro (PRESIDENT OF CORPORATION) |
Authorized Official Contact | 2099481583 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Diego F Ferro Md Inc 420 W Acacia St Suite 1 Stockton CA 95203-2441 Ph: (209) 948-1583 | Diego F Ferro Md Inc 420 W Acacia St Suite 1 Stockton CA 95203-2441 Ph: (209) 948-1583 |
NPI Number | 1174880835 |
---|---|
Provider Enumeration Date | 04/19/2012 |
Last Update Date | 10/27/2014 |
Medicare PECOS PAC ID | 2062677594 |
---|---|
Medicare Enrollment ID | O20120706000134 |
News Archive
Your best side may be your left cheek, according to a new study by Kelsey Blackburn and James Schirillo from Wake Forest University in the US. Their work shows that images of the left side of the face are perceived and rated as more pleasant than pictures of the right side of the face, possibly due to the fact that we present a greater intensity of emotion on the left side of our face.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Marken announced today that they won the pharmaceutical clinical research industry award of Best Life Science Logistics Provider at the 5th Annual BioPharma Asia Industry Awards. The award was announced at a dinner and ceremony held in conjunction with the BioPharma Asia conference in Singapore, drawing an annual attendance of 1600.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
› Verified 2 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1174880835 | NPI | - | NPPES |
1174880835 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | A106012 (California) | Primary |
Provider Name | Diego F Ferro |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1700027877 PECOS PAC ID: 2769660877 Enrollment ID: I20110620000527 |
News Archive
Your best side may be your left cheek, according to a new study by Kelsey Blackburn and James Schirillo from Wake Forest University in the US. Their work shows that images of the left side of the face are perceived and rated as more pleasant than pictures of the right side of the face, possibly due to the fact that we present a greater intensity of emotion on the left side of our face.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Marken announced today that they won the pharmaceutical clinical research industry award of Best Life Science Logistics Provider at the 5th Annual BioPharma Asia Industry Awards. The award was announced at a dinner and ceremony held in conjunction with the BioPharma Asia conference in Singapore, drawing an annual attendance of 1600.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
› Verified 2 days ago
Provider Name | Julie Ann Basler |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1770289043 PECOS PAC ID: 0941664973 Enrollment ID: I20230911000087 |
News Archive
Your best side may be your left cheek, according to a new study by Kelsey Blackburn and James Schirillo from Wake Forest University in the US. Their work shows that images of the left side of the face are perceived and rated as more pleasant than pictures of the right side of the face, possibly due to the fact that we present a greater intensity of emotion on the left side of our face.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Marken announced today that they won the pharmaceutical clinical research industry award of Best Life Science Logistics Provider at the 5th Annual BioPharma Asia Industry Awards. The award was announced at a dinner and ceremony held in conjunction with the BioPharma Asia conference in Singapore, drawing an annual attendance of 1600.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
› Verified 2 days ago
News Archive
Your best side may be your left cheek, according to a new study by Kelsey Blackburn and James Schirillo from Wake Forest University in the US. Their work shows that images of the left side of the face are perceived and rated as more pleasant than pictures of the right side of the face, possibly due to the fact that we present a greater intensity of emotion on the left side of our face.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Marken announced today that they won the pharmaceutical clinical research industry award of Best Life Science Logistics Provider at the 5th Annual BioPharma Asia Industry Awards. The award was announced at a dinner and ceremony held in conjunction with the BioPharma Asia conference in Singapore, drawing an annual attendance of 1600.
Rush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a new combination immunotherapy that targets different immune system cells and processes than a widely used therapy that has been proven effective for some patients but had little effect on others.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended September 30, 2010. Total revenues for the third quarter of 2010 were $1.94 billion, up 8 percent compared to total revenues of $1.80 billion for the third quarter of 2009. Net income for the third quarter of 2010 was $704.9 million, or $0.83 per diluted share, compared to net income for the third quarter of 2009 of $673.0 million, or $0.72 per diluted share.
› Verified 2 days ago
James H. Holmes, Jr., M.d., Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1502 St. Mark's Plaza, Suite 5, Stockton, CA 95207 Phone: 209-466-8683 Fax: 209-466-8309 | |
Dameron Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 530 W Acacia St, Stockton, CA 95203 Phone: 209-461-3196 Fax: 209-461-7593 | |
Kulendu G Vasavda Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 221 Tuxedo Court, Suite B, Stockton, CA 95204 Phone: 209-941-0149 Fax: 209-941-2550 | |
Ht Family Physicians, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 77 W March Ln, Suite A, Stockton, CA 95207 Phone: 209-477-5552 Fax: 209-477-5553 | |
San Joaquin County Clinics Chs Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1414 N California St Suite A, Stockton, CA 95202 Phone: 209-953-6400 Fax: 209-468-2321 | |
American Current Care Of California, A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 702 W Hammer Ln, Stockton, CA 95210 Phone: 209-546-7767 Fax: 209-546-7785 | |
Sunny Mann Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2216 N California St Ste A, Stockton, CA 95204 Phone: 209-851-2065 Fax: 209-292-8910 |